UREMIC PATIENTS HAVE NORMAL PLASMA AND PLATELET VONWILLEBRAND-FACTOR STRUCTURE, REGARDLESS OF BLEEDING-TIME

被引：0
|
作者：
CASTAMAN, G
RODEGHIERO, F
LATTUADA, A
CONZ, P
LAGRECA, G
MANNUCCI, PM
机构：
[1] SAN BORTOLO HOSP,DEPT HEMATOL,VICENZA,ITALY
[2] SAN BORTOLO HOSP,DEPT NEPHROL,VICENZA,ITALY
[3] SAN BORTOLO HOSP,CTR HEMOPHILIA & THROMBOSIS,VICENZA,ITALY
[4] UNIV MILAN,A BIANCHI BONOMI HEMOPHILIA & THROMBOSIS CTR,I-20122 MILAN,ITALY
来源：
THROMBOSIS RESEARCH | 1993年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [1] CORRECTION OF THE BLEEDING-TIME IN TREATED PATIENTS WITH SEVERE VONWILLEBRAND DISEASE IS NOT SOLELY DEPENDENT ON THE NORMAL MULTIMERIC STRUCTURE OF PLASMA VONWILLEBRAND-FACTOR
    MANNUCCI, PM
    MOIA, M
    REBULLA, P
    ALTIERI, D
    MONTEAGUDO, J
    CASTILLO, R
    AMERICAN JOURNAL OF HEMATOLOGY, 1987, 25 (01) : 55 - 65
  • [2] BLEEDING-TIME IN TREATED PATIENTS WITH SEVERE VONWILLEBRAND DISEASE IS NOT CORRECTED ONLY BY GIVING NORMAL MULTIMERIC PLASMA VONWILLEBRAND-FACTOR
    MANNUCCI, PM
    MOIA, M
    ALTIERI, D
    MONTEAGUDO, J
    CASTILLO, R
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 362 - 362
  • [3] THE EFFECT OF DDAVP ON PLASMA AND PLATELET VONWILLEBRAND-FACTOR MULTIMERIC PATTERN AND BLEEDING-TIME IN PATIENTS WITH CONGENITAL PLATELET-FUNCTION DEFECTS
    OKSANEN, K
    KEKOMAKI, R
    LINDBOM, A
    MYLLYLA, G
    RASI, V
    VAHTERA, E
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 517 - 517
  • [4] BLEEDING-TIME, BLOOD-GROUPS AND VONWILLEBRAND-FACTOR
    CAEKEBEKEPEERLINCK, KMJ
    KOSTER, T
    BRIET, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (02) : 217 - 220
  • [5] THE BLEEDING-TIME IN NORMAL SUBJECTS IS MAINLY DETERMINED BY PLATELET VONWILLEBRAND-FACTOR AND IS INDEPENDENT FROM BLOOD-GROUP
    RODEGHIERO, F
    CASTAMAN, G
    RUGGERI, M
    TOSETTO, A
    THROMBOSIS RESEARCH, 1992, 65 (4-5) : 605 - 615
  • [6] A REASSESSMENT OF THE BLEEDING-TIME - ASSOCIATION OF AGE, HEMATOCRIT, PLATELET-FUNCTION, VONWILLEBRAND-FACTOR, AND BLEEDING-TIME THROMBOXANE-B2 WITH THE LENGTH OF THE BLEEDING-TIME
    GERRARD, JM
    DOCHERTY, JC
    ISRAELS, SJ
    CHEANG, MS
    BISHOP, AJ
    KOBRINSKY, NL
    SCHROEDER, ML
    ISRAELS, ED
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1989, 12 (03): : 165 - 171
  • [7] PLASMA COLLAGEN COFACTOR CORRELATES WITH VONWILLEBRAND-FACTOR ANTIGEN AND RISTOCETIN COFACTOR BUT NOT WITH BLEEDING-TIME
    AIHARA, M
    KIMURA, A
    CHIBA, Y
    YOSHIDA, Y
    THROMBOSIS AND HAEMOSTASIS, 1988, 59 (03) : 485 - 490
  • [8] PLATELET VONWILLEBRAND-FACTOR - COMPARISON TO PLASMA VONWILLEBRAND-FACTOR
    GRALNICK, HR
    WILLIAMS, SB
    MCKEOWN, LP
    KRIZEK, DM
    RICK, ME
    CIRCULATION, 1984, 70 (04) : 98 - 98
  • [9] PLATELET VONWILLEBRAND-FACTOR - COMPARISON WITH PLASMA VONWILLEBRAND-FACTOR
    GRALNICK, HR
    WILLIAMS, SB
    MCKEOWN, LP
    KRIZEK, DM
    SHAFER, BC
    RICK, ME
    THROMBOSIS RESEARCH, 1985, 38 (06) : 623 - 633
  • [10] PLATELET VONWILLEBRAND-FACTOR - AN IMPORTANT DETERMINANT OF THE BLEEDING-TIME IN TYPE-I VONWILLEBRANDS DISEASE
    GRALNICK, HR
    RICK, ME
    MCKEOWN, LP
    WILLIAMS, SB
    PARKER, RI
    MAISONNEUVE, P
    JENNEAU, C
    SULTAN, Y
    THROMBOSIS RESEARCH, 1986, : 102 - 102
12345